hybrid silica
Recently Published Documents


TOTAL DOCUMENTS

509
(FIVE YEARS 88)

H-INDEX

49
(FIVE YEARS 6)

Catalysts ◽  
2021 ◽  
Vol 11 (11) ◽  
pp. 1391
Author(s):  
Michael Meistelman ◽  
Dan Meyerstein ◽  
Ariela Burg ◽  
Dror Shamir ◽  
Yael Albo

Reduction of nitrobenzene with NaBH4 using zero-valent iron nanoparticles (ZVI-NPs) and NiCl2∙6H2O incorporated in organically modified hybrid silica matrices as ZVI@ORMOSIL and Ni(II)@ORMOSIL catalysts is proposed as a remediation strategy. Ni(II)@ORMOSIL is prepared by ion-exchanging H+ of the ORMOSIL matrix with NiII. Ni(II)@ORMOSIL is a pre-catalyst that undergoes reduction by NaBH4 by an in-situ reaction and promotes nitrobenzene reduction by the unconsumed NaBH4, leading to sparing use of the catalyst. Ni(II)@ORMOSIL undergoes color change from green to black in this process, returning to a green hue after washing and drying. Nitrobenzene reductions were examined in aqueous acetonitrile solvent mixtures, and the reduction cascade produced the reaction end-products with catalytic implications. Plausible mechanisms of ZVI@ORMOSIL and Ni(II)@ORMOSIL catalyzed reductions of nitrobenzene are discussed. This work is the first to report M(II)@ORMOSIL pre-catalysts for in-situ reduction of nitrobenzene, and expands the scope of the ORMOSIL series of catalysts for the reduction of polluting compounds. This approach enables the development of catalysts that use very low concentrations of transition metal cations.


Nanomaterials ◽  
2021 ◽  
Vol 11 (11) ◽  
pp. 2893
Author(s):  
Eduardo J. Cueto-Díaz ◽  
Alberto Castro-Muñiz ◽  
Fabián Suárez-García ◽  
Santos Gálvez-Martínez ◽  
Mª Carmen Torquemada-Vico ◽  
...  

In this work, we have described the characterization of hybrid silica nanoparticles of 50 nm size, showing outstanding size homogeneity, a large surface area, and remarkable CO2 sorption/desorption capabilities. A wide battery of techniques was conducted ranging from spectroscopies such as: UV-Vis and IR, to microscopies (SEM, AFM) and CO2 sorption/desorption isotherms, thus with the purpose of the full characterization of the material. The bare SiO2 (50 nm) nanoparticles modified with 3-aminopropyl (triethoxysilane), APTES@SiO2 (50 nm), show a remarkable CO2 sequestration enhancement compared to the pristine material (0.57 vs. 0.80 mmol/g respectively at 50 °C). Furthermore, when comparing them to their 200 nm size counterparts (SiO2 (200 nm) and APTES@SiO2 (200 nm)), there is a marked CO2 capture increment as a consequence of their significantly larger micropore volume (0.25 cm3/g). Additionally, ideal absorbed solution theory (IAST) was conducted to determine the CO2/N2 selectivity at 25 and 50 °C of the four materials of study, which turned out to be >70, being in the range of performance of the most efficient microporous materials reported to date, even surpassing those based on silica.


2021 ◽  
Vol 22 (20) ◽  
pp. 11228
Author(s):  
Barbara Carrese ◽  
Chiara Cavallini ◽  
Gennaro Sanità ◽  
Paolo Armanetti ◽  
Brigida Silvestri ◽  
...  

Hybrid nanomaterials have attracted research interest owing to their intriguing properties, which may offer new diagnostic options with triggering features, able to realize a new kind of tunable nanotherapeutics. Hybrid silica/melanin nanoparticles (NPs) containing silver seeds (Me-laSil_Ag-HSA NPs) disclosed relevant photoacoustic contrast for molecular imaging. In this study we explored therapeutic function in the same nanoplatform. For this purpose, MelaSil_Ag-HSA were loaded with doxorubicin (DOX) (MelaSil_Ag-HSA@DOX) and tested to assess the efficiency of drug delivery combined with concurrent photothermal treatment. The excellent photothermal properties allowed enhanced cytotoxic activity at significantly lower doses than neat chemotherapeutic treatment. The results revealed that MelaSil_Ag-HSA@DOX is a promising platform for an integrated photothermal (PT) chemotherapy approach, reducing the efficacy concentration of the DOX and, thus, potentially limiting the several adverse side effects of the drug in in vivo treatments.


Sign in / Sign up

Export Citation Format

Share Document